We are live on ! Find out more
NA

NewEdge Advisors Portfolio holdings

AUM $27.7B
1-Year Est. Return 22.98%
This Fund
S&P 500
This Quarter Est. Return
+3.42%
1 Year Est. Return
+22.98%
3 Year Est. Return
+69.07%
5 Year Est. Return
+86.55%
10 Year Est. Return
+264.51%
AUM
$13.7B
AUM Growth
+$2.27B
Cap. Flow
+$2.05B
Cap. Flow %
14.94%
Top 10 Hldgs %
20.25%
Holding
4,072
New
258
Increased
1,574
Reduced
1,252
Closed
284

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$166M
2
NVDA icon
NVIDIA
NVDA
+$72.4M
3
IVW icon
iShares S&P 500 Growth ETF
IVW
+$59.8M
4
AAPL icon
Apple
AAPL
+$43.5M
5
IVV icon
iShares Core S&P 500 ETF
IVV
+$35.6M

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$28.6M
2
SPTI icon
State Street SPDR Portfolio Intermediate Term Treasury ETF
SPTI
+$18M
3
MCD icon
McDonald's
MCD
+$15.5M
4
IBDX icon
iShares iBonds Dec 2032 Term Corporate ETF
IBDX
+$8.45M
5
SHM icon
State Street SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
+$6.17M

Sector Composition

Rank Sector Weight
1 Technology 15.43%
2 Financials 5.84%
3 Healthcare 5.21%
4 Consumer Discretionary 4.33%
5 Industrials 3.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ONLN icon
3576
ProShares Online Retail ETF
ONLN
$66.2M
$447 ﹤0.01%
11
– –
TLPH icon
3577
Talphera
TLPH
$68M
$445 ﹤0.01%
500
– –
CVAC
3578
DELISTED
CureVac
CVAC
$439 ﹤0.01%
129
– –
SHCO
3579
DELISTED
Soho House & Co
SHCO
$435 ﹤0.01%
82
– –
UHAL icon
3580
U-Haul Holding Co
UHAL
$13.7B
$432 ﹤0.01%
7
-65
-90% -$4.23K
BPMC
3581
DELISTED
Blueprint Medicines
BPMC
$431 ﹤0.01%
4
– –
OMEX icon
3582
Odyssey Marine Exploration
OMEX
$36.3M
$410 ﹤0.01%
84
– –
MRVI icon
3583
Maravai LifeSciences
MRVI
$957M
$408 ﹤0.01%
57
-362
-86% -$3.13K
GGZ
3584
Gabelli Global Small and Mid-Cap Value Trust
GGZ
$125M
$406 ﹤0.01%
36
– –
ASTH icon
3585
Astrana Health
ASTH
$1.75B
$406 ﹤0.01%
+10
New +$397
GTIP icon
3586
Goldman Sachs Access Inflation Protected USD Bond ETF
GTIP
$292M
$404 ﹤0.01%
8
-180
-96% -$8.7K
BIVI icon
3587
BioVie
BIVI
$10.7M
$401 ﹤0.01%
10
– –
GSIT icon
3588
GSI Technology
GSIT
$214M
$398 ﹤0.01%
150
– –
XPH icon
3589
State Street SPDR S&P Pharmaceuticals ETF
XPH
$476M
$398 ﹤0.01%
10
– –
XRX icon
3590
Xerox
XRX
$403M
$395 ﹤0.01%
34
-50
-60% -$726
QTTB icon
3591
Q32 Bio
QTTB
$461M
$395 ﹤0.01%
22
-3
-12% -$72
BNKK
3592
Bonk Inc
BNKK
$7.82M
$389 ﹤0.01%
10
– –
VSXY
3593
Victoria's Secret
VSXY
$7.06B
$389 ﹤0.01%
22
-159
-88% -$3.03K
CLFD icon
3594
Clearfield
CLFD
$419M
$386 ﹤0.01%
10
– –
LEVI icon
3595
Levi Strauss
LEVI
$9.53B
$386 ﹤0.01%
20
+19
+1,900% +$416
TGI
3596
DELISTED
Triumph Group
TGI
$385 ﹤0.01%
25
– –
PEZ icon
3597
Invesco Dorsey Wright Consumer Cyclicals Momentum ETF
PEZ
$22.5M
$384 ﹤0.01%
4
– –
FWRD icon
3598
Forward Air
FWRD
$448M
$381 ﹤0.01%
20
– –
RTB
3599
RTB Digital
RTB
$221M
$381 ﹤0.01%
7
– –
ACB
3600
Aurora Cannabis
ACB
$172M
$379 ﹤0.01%
82
– –
142 143
144
145 146

Similar funds

FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
TWC
The Woodbridge Company Toronto, Ontario, Canada $27.8B AUM 46.78% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $27B AUM 24.49% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

NewEdge Advisors's Q2 2024 Portfolio in Review

As of Q2 2024, NewEdge Advisors held 4,072 positions worth $13.7B, up 20% from $11.5B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

NewEdge Advisors deployed $2.05B of net new capital in Q2 2024, opening 258 new positions and adding to 1,574 existing holdings. Its largest new stake was AB Short Duration High Yield ETF: 560,020 shares worth $19.7M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Novartis, an estimated $28.6M trimmed.

  • NewEdge Advisors's largest Q2 2024 buy was AB Short Duration High Yield ETF: 560,020 shares worth $19.7M.
  • NewEdge Advisors added most to State Street SPDR S&P 500 ETF Trust in Q2 2024, an estimated $166M increase.
  • NewEdge Advisors's biggest Q2 2024 reduction was Novartis, cutting an estimated $28.6M.
  • NewEdge Advisors fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $4.96M.
  • NewEdge Advisors's ten largest holdings make up 20% of its $13.7B portfolio in Q2 2024.
  • NewEdge Advisors opened 258 new positions and closed 284 in Q2 2024.
  • NewEdge Advisors's portfolio value rose 20% quarter-over-quarter to $13.7B.

Based on NewEdge Advisors's 13F filing for Q2 2024, filed 16 Aug 2024.